We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05153408
Recruitment Status : Recruiting
First Posted : December 10, 2021
Last Update Posted : June 24, 2022
Information provided by (Responsible Party):
Blueprint Medicines Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 10, 2024
Estimated Study Completion Date : December 10, 2024